These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32110050)

  • 21. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
    Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
    Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR-199a-3p.
    Wang X; Zou J; Chen H; Zhang P; Lu Z; You Z; Sun J
    IUBMB Life; 2019 Oct; 71(10):1482-1491. PubMed ID: 31169973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer.
    Xie FW; Liu JC
    Kaohsiung J Med Sci; 2021 Aug; 37(8):664-674. PubMed ID: 34002487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2.
    Mao W; Wang S; Chen R; He Y; Lu R; Zheng M
    Open Med (Wars); 2022; 17(1):1538-1549. PubMed ID: 36245705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling.
    Zhu Q; Zhang Y; Li M; Zhang Y; Zhang H; Chen J; Liu Z; Yuan P; Yang Z; Wang X
    Biomark Res; 2023 Jan; 11(1):1. PubMed ID: 36600320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 31. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q; Xing S; Peng A; Yu Z
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis.
    Chen S; Hong K; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24347. PubMed ID: 35302673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis.
    Wu PF; Tang XM; Sun HL; Jiang HT; Ma J; Kong YH
    Neoplasma; 2021 Jul; 68(4):798-809. PubMed ID: 34348465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
    Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
    Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA NORAD promotes thyroid carcinoma progression by targeting miR-451.
    Shi L; Cong YZ; Wang ZJ
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6187-6195. PubMed ID: 34730199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA NORAD stimulates proliferation and migration of renal cancer via activating the miR-144-3p/MYCN axis.
    Zhao W; Wang L; Xu F
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10426-10432. PubMed ID: 33155199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-coding RNA Activated by DNA Damage: Review of Its Roles in the Carcinogenesis.
    Ghafouri-Fard S; Azimi T; Hussen BM; Abak A; Taheri M; Dilmaghani NA
    Front Cell Dev Biol; 2021; 9():714787. PubMed ID: 34485302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway.
    Xu X; Tao R; Sun L; Ji X
    Cancer Cell Int; 2020 Nov; 20(1):552. PubMed ID: 33292236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.